These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 33944714)

  • 21. [Raynaud's phenomenon and sclerodermia].
    Ezquerra Gadea J; López Larrayoz I; García Cores F; García Muñoz M
    Aten Primaria; 2003 Jun; 32(1):60. PubMed ID: 12812693
    [No Abstract]   [Full Text] [Related]  

  • 22. [Raynaud's phenomenon in the tongue of a patient with sclerodermia].
    Klemp P; Staberg B; Thomsen K
    Ugeskr Laeger; 1983 Jan; 145(5):333. PubMed ID: 6845496
    [No Abstract]   [Full Text] [Related]  

  • 23. [Raynaud's disease, acrocyanosis and scleroderma in the menopause].
    Lo Stumbo F; Banchelli A
    Minerva Ginecol; 1965 Nov; 17(21):1034-43. PubMed ID: 5880755
    [No Abstract]   [Full Text] [Related]  

  • 24. Raynaud's phenomenon with incomplete features of scleroderma: a wolf in sheep's clothing and a possible new indication for pulmonary/heart graft.
    Vayssairat M; Gouny P; Nussaume O
    Dermatology; 1994; 188(1):80. PubMed ID: 8305768
    [No Abstract]   [Full Text] [Related]  

  • 25. [One stage parathyroidectomy and stellectomy for Raynaud's disease associated with scleroderma].
    ARMENIO S; VEGNI L
    Atti Accad Fisiocrit Siena Med Fis; 1955; 2():444-51. PubMed ID: 13341699
    [No Abstract]   [Full Text] [Related]  

  • 26. Studies of endogenous catecholamines in patients with Raynaud's phenomenon secondary to progressive systemic sclerosis (scleroderma).
    Sapira JD; Rodnan GP; Scheib ET; Klaniecki T; Rizk M
    Am J Med; 1972 Mar; 52(3):330-7. PubMed ID: 4551793
    [No Abstract]   [Full Text] [Related]  

  • 27. Migraine and systemic scleroderma.
    Goldberg NC; Duncan SC; Winkelmann RK
    Arch Dermatol; 1978 Apr; 114(4):550-1. PubMed ID: 646367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of Raynaud's phenomenon with captopril.
    Tosi S; Marchesoni A; Messina K; Bellintani C; Sironi G; Faravelli C
    Drugs Exp Clin Res; 1987; 13(1):37-42. PubMed ID: 3297593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Heart lesions in progressive systemic sclerosis. Intramyocardial Raynaud's phenomenon].
    Frandsen NE
    Ugeskr Laeger; 1980 May; 142(22):1423-4. PubMed ID: 7404748
    [No Abstract]   [Full Text] [Related]  

  • 30. Raynaud's phenomenon of the tongue.
    Grémain V; Richard L; Langlois V; Marie I
    Joint Bone Spine; 2017 Mar; 84(2):231. PubMed ID: 27269655
    [No Abstract]   [Full Text] [Related]  

  • 31. Interstitial calcinosis and scleroderma associated with rheumatoid arthritis and Raynaud's disease.5A case report.
    Sherman BD
    J Am Podiatry Assoc; 1968 Feb; 58(2):68-71. PubMed ID: 5636488
    [No Abstract]   [Full Text] [Related]  

  • 32. CRST syndrome with persistent gastrointestinal bleeding. (Calcinosis, raynaud's phenomenon, sclerodactyly and telangiectasia).
    Kolodny M; Baker WG
    Gastrointest Endosc; 1968 Aug; 15(1):16-7. PubMed ID: 5302707
    [No Abstract]   [Full Text] [Related]  

  • 33. A new syndrome with pigmentation, scleroderma, gynaecomastia, Raynaud's phenomenon and peripheral neuropathy.
    Saihan EM; Burton JL; Heaton KW
    Br J Dermatol; 1978 Oct; 99(4):437-40. PubMed ID: 213095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Scleroderma, pulmonary hypertension and Raynaud's syndrome].
    Duclós F; Bohórquez A; Zambrano A; Armenta J
    Rev Esp Cardiol; 1968 Apr; 21(2):223-33. PubMed ID: 5739705
    [No Abstract]   [Full Text] [Related]  

  • 35. [Incomplete Raynaud's syndrome with extensive osteolysis, acrosclerosis, multiple visceral lesions. Systemic scleroderma].
    Michel PJ; Frieh P; Cretin J; Cassin B
    Bull Soc Fr Dermatol Syphiligr; 1967; 74(4):526-31. PubMed ID: 5585213
    [No Abstract]   [Full Text] [Related]  

  • 36. [Systemic scleroderma in children].
    Plantin P; Gavanou J; Le Fur JM; Guillet G
    Arch Fr Pediatr; 1988 Dec; 45(10):805-8. PubMed ID: 3266459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The diagnosis of Raynaud's phenomenon.
    Coffman JD
    Clin Dermatol; 1994; 12(2):283-9. PubMed ID: 8076267
    [No Abstract]   [Full Text] [Related]  

  • 38. A randomised double-blind trial of diltiazem in the treatment of Raynaud's phenomenon.
    Kahan A; Amor B; Menkes CJ
    Ann Rheum Dis; 1985 Jan; 44(1):30-3. PubMed ID: 3882061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Raynaud's disease as a manifestation of generalized vascular disorders in systemic scleroderma].
    Guseva NG
    Kardiologiia; 1973 Oct; 13(10):76-82. PubMed ID: 4781474
    [No Abstract]   [Full Text] [Related]  

  • 40. Increased pulmonary artery pressure in association with Raynaud's phenomenon.
    Ohar JM; Robichaud AM; Fowler AA; Glauser FL
    Am J Med; 1986 Aug; 81(2):361-2. PubMed ID: 3740093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.